These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

825 related articles for article (PubMed ID: 34421350)

  • 1. The functional roles, cross-talk and clinical implications of m6A modification and circRNA in hepatocellular carcinoma.
    Qin S; Mao Y; Chen X; Xiao J; Qin Y; Zhao L
    Int J Biol Sci; 2021; 17(12):3059-3079. PubMed ID: 34421350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of YAP1 by N6-Methyladenosine-Modified circCPSF6 Drives Malignancy in Hepatocellular Carcinoma.
    Chen Y; Ling Z; Cai X; Xu Y; Lv Z; Man D; Ge J; Yu C; Zhang D; Zhang Y; Xie H; Zhou L; Wu J; Zheng S
    Cancer Res; 2022 Feb; 82(4):599-614. PubMed ID: 34916222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α.
    Yang N; Wang T; Li Q; Han F; Wang Z; Zhu R; Zhou J
    J Cell Physiol; 2021 May; 236(5):3863-3880. PubMed ID: 33305825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of circular RNAs in the development of hepatocellular carcinoma.
    Hussen BM; Honarmand Tamizkar K; Hidayat HJ; Taheri M; Ghafouri-Fard S
    Pathol Res Pract; 2021 Jul; 223():153495. PubMed ID: 34051512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N
    Xu J; Wan Z; Tang M; Lin Z; Jiang S; Ji L; Gorshkov K; Mao Q; Xia S; Cen D; Zheng J; Liang X; Cai X
    Mol Cancer; 2020 Nov; 19(1):163. PubMed ID: 33222692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-talk between circRNAs and m6A modifications in solid tumors.
    Liu F; Gu W; Shao Y
    J Transl Med; 2024 Jul; 22(1):694. PubMed ID: 39075555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N
    Rao X; Lai L; Li X; Wang L; Li A; Yang Q
    IUBMB Life; 2021 Feb; 73(2):408-417. PubMed ID: 33372396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of circular RNAs and N6-methyladenosine (m6A) modification on cancer biology.
    Zhang G; Hou J; Mei C; Wang X; Wang Y; Wang K
    Biomed Pharmacother; 2023 Mar; 159():114260. PubMed ID: 36657303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p/TXNDC5 signaling pathway.
    Yu J; Yang M; Zhou B; Luo J; Zhang Z; Zhang W; Yan Z
    Clin Sci (Lond); 2019 Jul; 133(13):1487-1503. PubMed ID: 31278132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA Circ100084 functions as sponge of miR‑23a‑5p to regulate IGF2 expression in hepatocellular carcinoma.
    Yang J; Li Y; Yu Z; Zhou Y; Tu J; Lou J; Wang Y
    Mol Med Rep; 2020 Jun; 21(6):2395-2404. PubMed ID: 32323783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma.
    Zuo X; Chen Z; Gao W; Zhang Y; Wang J; Wang J; Cao M; Cai J; Wu J; Wang X
    J Hematol Oncol; 2020 Jan; 13(1):5. PubMed ID: 31915027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression pattern and prognostic value of N6-methyladenosine RNA methylation key regulators in hepatocellular carcinoma.
    Deng M; Fang L; Li SH; Zhao RC; Mei J; Zou JW; Wei W; Guo RP
    Mutagenesis; 2021 Oct; 36(5):369-379. PubMed ID: 34467992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CircRNA-5692 inhibits the progression of hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP expression.
    Liu Z; Yu Y; Huang Z; Kong Y; Hu X; Xiao W; Quan J; Fan X
    Cell Death Dis; 2019 Nov; 10(12):900. PubMed ID: 31776329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NUDT21 regulates circRNA cyclization and ceRNA crosstalk in hepatocellular carcinoma.
    Li X; Ding J; Wang X; Cheng Z; Zhu Q
    Oncogene; 2020 Jan; 39(4):891-904. PubMed ID: 31570791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA circ-102,166 acts as a sponge of miR-182 and miR-184 to suppress hepatocellular carcinoma proliferation and invasion.
    Li R; Deng Y; Liang J; Hu Z; Li X; Liu H; Wang G; Fu B; Zhang T; Zhang Q; Yang Y; Chen G; Liu W
    Cell Oncol (Dordr); 2021 Apr; 44(2):279-295. PubMed ID: 33034848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple m
    Qu N; Qin S; Zhang X; Bo X; Liu Z; Tan C; Wen G; Jiang H
    BMC Cancer; 2020 Feb; 20(1):165. PubMed ID: 32111180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALKBH5 suppresses malignancy of hepatocellular carcinoma via m
    Chen Y; Zhao Y; Chen J; Peng C; Zhang Y; Tong R; Cheng Q; Yang B; Feng X; Lu Y; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2020 Aug; 19(1):123. PubMed ID: 32772918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosstalk between m6A modification and non-coding RNAs in HCC.
    Qiu Z; Yuan X; Wang X; Liu S
    Cell Signal; 2024 May; 117():111076. PubMed ID: 38309550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive analysis of N6-methyladenosine -related long non-coding RNAs and immune cell infiltration in hepatocellular carcinoma.
    Yu ZL; Zhu ZM
    Bioengineered; 2021 Dec; 12(1):1708-1724. PubMed ID: 33955330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.